CYBB and diabetes mellitus: Several studies have demonstrated that NOX2 is overexpressed in diabetes, promoting activation of the NF-κB pathway, production of pro-inflammatory cytokines (IL-6, TNF-α, COX-2), and increased circulating CRP, a classic marker of systemic inflammation (12–14).